Parkman Healthcare Partners specializes in healthcare investments across various subsectors, including biotech, pharma, medical devices, diagnostics, life science research, and services. Based in Stamford, CT, the firm takes a global approach to identifying innovations and opportunities. Their investment strategy focuses on protecting and growing capital through an evidence-based approach.
The firm's portfolio includes notable companies such as Stereotaxis and Vyne Therapeutics. Parkman Healthcare Partners leverages deep industry experience and intellectual curiosity to drive their investment decisions. They typically engage in post-IPO equity rounds, demonstrating their commitment to supporting companies throughout their growth stages.
Portfolio Snapshot
Observed round participation, including acquisitions and grants. Current holdings, investor exits, and write-offs are not established.
